INGN News and Press, Inogen Inc From 02/24/22

Inogen press release (NASDAQ:INGN): Q4 GAAP EPS of -$1.01 misses by $0.30. Revenue of $76.4M (+3.3% Y/Y) misses by $0.2M. For further details see: Inogen GAAP EPS of -$1.01 misses by $0.30, revenue of $76.4M misses by $0.2M

– Q4 2021 Total Revenue increased 3.3% year-over-year to $76.4 million – Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the th...

Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release fourth quarter 2021 financial results after market close on Thursday, February 24, 2022. The Company will host a c...

– Q4 2021 Total Preliminary Revenue of $75.9 to $76.9 million – – Provides Supply Chain and EU Operations Update – Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use ...

- Ray Huggenberger Retires from Board - Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Elizabeth (Beth) Mora was elected as Board Chairperson. Ms. Mora has served as...

Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s presentation at the 40 th Annual J.P. Morgan Healthcare Conference has been moved due to the confere...

Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 40 th Annual J.P. Morgan Healthcare Conference. Inogen&#...

Inogen (NASDAQ:INGN) appoints Mike Sergesketter as interim CFO, succeeding Alison Bauerlein who will be staying with the Company in a transitional finance role through the 1Q22. The Company has retained a leading executive search firm to help with the search for a permanen...

– Names Mike Sergesketter as Interim Chief Financial Officer – Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Mike Sergesketter as Interi...

With the sharpest gain in four months, Inogen (INGN +5.1%) shares have reached a one-month high after Needham upgraded the stock to Buy from Hold, noting an improvement in its supply chain issues. Early November, Inogen (NASDAQ:INGN) management attributed supply chain problems in the semicond...